 OXFORD, United Kingdom and MARLBOROUGH, Mass., April 21, 2020 GLOBE NEWSWIRE -- Oxford Immunotec Global PLC OXFD, a global, high-growth diagnostics company, today announced that it has successfully obtained re-registration of the T-SPOT.TB test in China. The re-registration was granted by the Chinese National Medical Products Administration NMPA on April 13, 2020 and, as is customary, the registration lasts until April 12, 2025 whereupon it will need to be renewed. As a Class III medical device, Chinas Medical Device Registration Regulations and subsequent policies require that the company apply to the Center for Medical Device Evaluation CMDE of the National Medical Products Administration NMPA to renew its license for the T-SPOT.TB test every five years. 